Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

Fate Therapeutics (NASDAQ:FATE – Free Report) had its target price trimmed by Wells Fargo & Company from $5.00 to $4.00 in a ...

StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock. Several other brokerages have ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (the "Company"), a biopharmaceutical company dedicated to ...

As the U.S. stock market faces a turbulent period with major indices like the Dow Jones and S&P 500 on track for their worst week in two years, concerns about tariffs and economic health continue to ...

Benitec Biopharma Inc.’s BNTC share price has surged by 11.39%, which has investors questioning if this is right time to sell ...

Stevanato's 2024 revenue hits €1.1B, driven by biopharma growth! Discover how facility expansions & rising demand are transforming their market impact.

We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 21.46%, which has investors questioning if this is right time to sell.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

which are available on the SEC’s website at www.sec.gov. Contacts AEON Biopharma NewsMORE Related Stocks ...